chna-csp-final-8-5-19-complete-1.pdf
... Centers at NYU Langone at: kathleen.hopkins@nyulangone.org. ii Table of Contents Section Pages MISSION 1 ... and Plans: Preventing Chronic Diseases 24-49 iii Section Pages A. Tobacco Free Community 24-31 B. Health ...
Diagnosing Epilepsy & Seizure Disorders | NYU Langone Health
NYU Langone specialists use exams and imaging tests to diagnose epilepsy and seizure disorders.
Sports Medicine Center | NYU Langone Health
Orthopedic surgeons and sports medicine doctors at NYU Langone’s Sports Medicine Center treat athletic, overuse, and everyday injuries.
acp-conversation-guide-english-fillable-2025.pdf
... goals from prolonging my life to a focus on my comfort? You should also consider talking to your ... Reflecting on your values and beliefs: When your health care agent (refer to page 3 for definition) and loved ...
acp-conversation-guide-english-printable-2025.pdf
... goals from prolonging my life to a focus on my comfort? You should also consider talking to your ... Reflecting on your values and beliefs: When your health care agent (refer to page 3 for definition) and loved ...
Child Study Center | NYU Langone Health
The Child Study Center, part of Hassenfeld Children’s Hospital at NYU Langone, treats children with mental health and developmental conditions.
A Phase 1 First in Human Study of ARV-393 in Adult Participants with Advanced Non-Hodgkin s Lymphoma
This is a multicenter, open-label Phase 1 study testing a new drug called ARV-393 in adults with advanced non-Hodgkin lymphoma (NHL). The study will look at the side effects of the drug, how well it works, and how the body processes it. Initially, the focus will be on ARV-393 by itself. To find the best dose, the study will group patients into sets of three. The goal is to find a dose that causes side effects in about 25% of patients. Doctors will decide whether to increase or decrease the dose based on the side effects and other information. There will be a waiting period of at least 24 hours between giving the first dose to the first patient in a group and the next doses. If the first patient does not have any side effects, more patients can receive that dose. If there are too many side effects, the dose will be lowered. Each dose level will include a small number of patients who will be closely monitored. If the rate of side effects is lower than the target, the dose can be increased; if it is higher than the target, the dose will be lowered. The study will stop if there are serious concerns about the side effects at any dose. When the dose escalation is finished, the best dose will be the one that results in the side effect rate closest to 25%.
Center for Blood Cancers | NYU Langone Health
Experts at the Center for Blood Cancers, part of Perlmutter Cancer Center, treat blood cancers such as leukemia, lymphoma, and multiple myeloma.
Diagnosing Epilepsy & Seizure Disorders in Children | NYU Langone Health
Experts at Hassenfeld Children’s Hospital at NYU Langone use exams, tests, and EEG to diagnose epilepsy and seizure disorders.
chna-winthrop-university-hospital-2016-final.pdf
... % 1 http://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml 5 from 2013. Race ... , Tri Care Systems DBA LIAAC 2 http://factfinder.census.gov/faces/tableservices/jsf/pages ...